These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 38660835
1. [Survival and Prognosis of Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes Transformed from Myelodysplastic Syndrome]. Shang LM, Chen HJ, Liu Y, Cao Y, Li F, Guo YT, Dong WM, Lin Y, Gu WY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):347-354. PubMed ID: 38660835 [Abstract] [Full Text] [Related]
2. The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine. Akimoto M, Sakurai A, Nishiyama-Fujita Y, Ito C, Aisa Y, Nakazato T. Ann Hematol; 2021 Apr; 100(4):953-957. PubMed ID: 33521864 [Abstract] [Full Text] [Related]
3. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis]. Zhang HX, Pang AM, Chen X, Zhang RL, Zhai WH, Ma QL, Yang DL, Wei JL, He Y, Feng SZ, Han MZ, Jiang EL. Zhonghua Xue Ye Xue Za Zhi; 2021 Oct 14; 42(10):814-822. PubMed ID: 34788920 [Abstract] [Full Text] [Related]
6. Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Harada K, Konuma T, Machida S, Mori J, Aoki J, Uchida N, Ohashi K, Fukuda T, Tanaka M, Ikegame K, Ozawa Y, Iwato K, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Yano S. Biol Blood Marrow Transplant; 2019 Sep 14; 25(9):1730-1743. PubMed ID: 31054982 [Abstract] [Full Text] [Related]
8. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors]. Xu XS, Ding H, Zhang X, Liao Y, Li H, Liu QY, Liu JZ, Zhang L, Huang J, Gong YP, Ma HB, Xiang B, Dai Y, Hou L, Shuai X, Niu T, Wu Y. Zhonghua Xue Ye Xue Za Zhi; 2023 Sep 14; 44(9):742-748. PubMed ID: 38049318 [Abstract] [Full Text] [Related]
9. [Clinical Analysis of Elderly Patients with AML/High-Risk MDS]. Xu WY, Wang F, Liu L, Ren XH, Liu PP, Zhang H, Zheng L, Zhang SS, Xu YR, Guo ZX. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct 14; 30(5):1311-1317. PubMed ID: 36208228 [Abstract] [Full Text] [Related]
10. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype. Prats-Martín C, Burillo-Sanz S, Morales-Camacho RM, Pérez-López O, Suito M, Vargas MT, Caballero-Velázquez T, Carrillo-Cruz E, González J, Bernal R, Pérez-Simón JA. Cancer Med; 2020 Jun 14; 9(11):3637-3646. PubMed ID: 32216059 [Abstract] [Full Text] [Related]
12. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. Montalban-Bravo G, Kanagal-Shamanna R, Class CA, Sasaki K, Ravandi F, Cortes JE, Daver N, Takahashi K, Short NJ, DiNardo CD, Jabbour E, Borthakur G, Naqvi K, Issa GC, Konopleva M, Khoury JD, Routbort M, Pierce S, Do KA, Bueso-Ramos C, Patel K, Kantarjian H, Garcia-Manero G, Kadia TM. Am J Hematol; 2020 Jun 14; 95(6):612-622. PubMed ID: 32112433 [Abstract] [Full Text] [Related]
14. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation. Britt A, Mohyuddin GR, McClune B, Singh A, Lin T, Ganguly S, Abhyankar S, Shune L, McGuirk J, Skikne B, Godwin A, Pessetto Z, Golem S, Divine C, Dias A. Leuk Res; 2020 Aug 14; 95():106402. PubMed ID: 32590108 [Abstract] [Full Text] [Related]
16. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC). Miesner M, Haferlach C, Bacher U, Weiss T, Macijewski K, Kohlmann A, Klein HU, Dugas M, Kern W, Schnittger S, Haferlach T. Blood; 2010 Oct 14; 116(15):2742-51. PubMed ID: 20581309 [Abstract] [Full Text] [Related]
17. [Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes]. Park SH, Chi HS, Park SJ, Jang S, Park CJ. Korean J Lab Med; 2010 Jun 14; 30(3):231-8. PubMed ID: 20603581 [Abstract] [Full Text] [Related]
19. [Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in MDS-EB and AML-MRC]. Liu J, Jia JS, Gong LZ, Lu SY, Zhu HH, Huang XJ, Jiang H. Zhonghua Xue Ye Xue Za Zhi; 2018 Sep 14; 39(9):734-738. PubMed ID: 30369183 [Abstract] [Full Text] [Related]